Phase II study as first line treatment for patients with advanced non-small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 09 Jul 2008
At a glance
- Drugs Cetuximab (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 09 Jul 2008 Added actual end date as reported by ClinicalTrials.gov.
- 09 Jul 2008 Status changed from in progress to completed, according to ClinicalTrials.gov.
- 06 Jun 2007 Results data presented at ASCO 2007.